AU6084598A - Antibiotic-ligand conjugates and methods of use thereof - Google Patents

Antibiotic-ligand conjugates and methods of use thereof

Info

Publication number
AU6084598A
AU6084598A AU60845/98A AU6084598A AU6084598A AU 6084598 A AU6084598 A AU 6084598A AU 60845/98 A AU60845/98 A AU 60845/98A AU 6084598 A AU6084598 A AU 6084598A AU 6084598 A AU6084598 A AU 6084598A
Authority
AU
Australia
Prior art keywords
antibiotic
methods
ligand conjugates
conjugates
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60845/98A
Inventor
Clifford A. Lingwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HSC Research and Development LP
Original Assignee
HSC Research and Development LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HSC Research and Development LP filed Critical HSC Research and Development LP
Publication of AU6084598A publication Critical patent/AU6084598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU60845/98A 1997-02-26 1998-02-26 Antibiotic-ligand conjugates and methods of use thereof Abandoned AU6084598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3916097P 1997-02-26 1997-02-26
US60039160 1997-02-26
PCT/CA1998/000142 WO1998037915A1 (en) 1997-02-26 1998-02-26 Antibiotic-ligand conjugates and methods of use thereof

Publications (1)

Publication Number Publication Date
AU6084598A true AU6084598A (en) 1998-09-18

Family

ID=21903984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60845/98A Abandoned AU6084598A (en) 1997-02-26 1998-02-26 Antibiotic-ligand conjugates and methods of use thereof

Country Status (2)

Country Link
AU (1) AU6084598A (en)
WO (1) WO1998037915A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043356A1 (en) * 1998-02-25 1999-09-02 Hsc Research Development Limited Partnership Antibiotic-ligand conjugates and methods of use thereof
JP4439119B2 (en) 1998-10-05 2010-03-24 株式会社ヤクルト本社 Antibacterial agent and production method thereof
AU2007200916B2 (en) * 1998-10-05 2009-09-17 Kabushiki Kaisha Yakult Honsha Antibacterial agents and process for producing the same
CN110680959B (en) * 2019-10-31 2021-12-03 江苏地韵医疗科技有限公司 Hydrogel for repairing multiple cross-linked meniscus and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500609A (en) * 1980-05-09 1982-04-08
JPH03504382A (en) * 1988-05-20 1991-09-26 ザ　リポソーム　カンパニー，インコーポレイテッド High ratio active agent: lipid complex
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
CA2095642C (en) * 1990-08-02 1999-12-14 Howard C. Krivan Adhesion receptors for pathogenic or opportunistic microorganisms
DK0563256T3 (en) * 1990-12-21 1995-08-28 Microcarb Inc Use of host cell phospholipids to inhibit bacterial colonization
WO1997018790A2 (en) * 1995-11-22 1997-05-29 The Research And Development Institute, Inc. Therapeutic and diagnostic agents for the treatment of microbial infections

Also Published As

Publication number Publication date
WO1998037915A1 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU6763898A (en) Gel sensors and methods of use thereof
AU7718898A (en) Txu-7-pap immunotoxin and use thereof
AU5752398A (en) Novel ketobenzamides and their use
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU9781998A (en) Huchordin and uses thereof
AU1616499A (en) Chemokine variants and methods of use
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU4266596A (en) Composition and use
AU3159499A (en) Antigen preparation and use
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU5874798A (en) Vaccination methods and molecules
AU9301998A (en) Composition and methods using galectin-1
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3118297A (en) Sok-1 and methods of use
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU8695298A (en) Compounds and uses thereof
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU1698899A (en) N-acetylserotonin derivatives and uses thereof
AU7681498A (en) Pharmaceutical composition and use thereof
AU4629399A (en) Substituted piperazones and their therapeutic uses
AUPO982097A0 (en) Methods and compositions for use therein